<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Altered expression of miRNAs is associated with development and progression of various human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> by regulating the translation of oncogenes and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, these regulators complement the Vogelstein multistep model of pathogenesis and have the potential of becoming a novel class of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biomarkers and therapeutic targets </plain></SENT>
<SENT sid="2" pm="."><plain>Using quantitative real-time PCR, we measured the expression of 621 mature miRNAs in 40 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and their paired <z:mpath ids='MPATH_458'>normal</z:mpath> tissues and identified 23 significantly deregulated miRNAs </plain></SENT>
<SENT sid="3" pm="."><plain>We subsequently evaluated their association with clinical characteristics of the samples and presence of alterations in the molecular markers of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
<SENT sid="4" pm="."><plain>Expression levels of miR-31 were correlated with CA19-9 and miR-18a, miR-21, and miR-31 were associated with mutations in APC gene </plain></SENT>
<SENT sid="5" pm="."><plain>To investigate the downstream regulation of the differentially expressed miRNAs identified, we integrated putative <z:chebi fb="2" ids="33699">mRNA</z:chebi> target predictions with the results of a meta-analysis of seven public gene expression datasets of <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Many of the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> deregulated miRNAs computationally mapped to targets involved in pathways related to progression </plain></SENT>
<SENT sid="7" pm="."><plain>Here one promising candidate pair (miR-1 and MET) was studied and functionally validated </plain></SENT>
<SENT sid="8" pm="."><plain>We show that miR-1 can have a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor function in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> by directly downregulating MET oncogene both at <z:chebi fb="40" ids="33697">RNA</z:chebi> and protein level and that reexpression of miR-1 leads to MET-driven reduction of cell proliferation and motility, identifying the miR-1 downmodulation as one of the events that could enhance <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
</text></document>